Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
XGN | EXAGEN INC. | Director | Jun 9, 2023 | |||
RPHM | Reneo Pharmaceuticals, Inc. | Chief Development Officer | Jul 14, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|